Biocryst Pharmaceuticals buy HC Wainwright
Start price
25.02.25
/
50%
€7.80
Target price
25.02.26
€28.57
Performance (%)
-22.22%
Price
17.12.25
€6.07
Summary
This prediction is currently active. The prediction for Biocryst Pharmaceuticals disappoints with a performance of -22.22%. This prediction currently runs until 25.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -7.413% | -7.413% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by HC_Wainwright for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.43
15.12.25
15.12.25
€27.26
15.12.26
15.12.26
-5.60%
17.12.25
17.12.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€9.65
06.05.25
06.05.25
€26.56
06.05.26
06.05.26
-37.10%
17.12.25
17.12.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.20
06.08.24
06.08.24
€27.50
06.08.25
06.08.25
1.14%
07.08.25
07.08.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
78.99%
08.05.25
08.05.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.90
04.08.23
04.08.23
€27.22
04.08.24
04.08.24
-7.45%
05.08.24
05.08.24